VanEck Associates’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.03M | Sell |
25,577
-4,623
| -15% | -$1.45M | 0.01% | 554 |
|
|
2025
Q1 | $9.2M | Buy |
30,200
+2,940
| +11% | +$896K | 0.01% | 506 |
|
|
2024
Q4 | $9.06M | Buy |
27,260
+7,027
| +35% | +$2.33M | 0.01% | 496 |
|
|
2024
Q3 | $6.68M | Buy |
20,233
+5,781
| +40% | +$1.91M | 0.01% | 559 |
|
|
2024
Q2 | $5.95M | Buy |
14,452
+3,251
| +29% | +$1.34M | 0.01% | 530 |
|
|
2024
Q1 | $4.53M | Buy |
11,201
+2,996
| +37% | +$1.21M | 0.01% | 618 |
|
|
2023
Q4 | $2.52M | Buy |
8,205
+2,258
| +38% | +$692K | ﹤0.01% | 743 |
|
|
2023
Q3 | $1.44M | Buy |
5,947
+1,783
| +43% | +$432K | ﹤0.01% | 805 |
|
|
2023
Q2 | $1M | Buy |
4,164
+182
| +5% | +$43.7K | ﹤0.01% | 867 |
|
|
2023
Q1 | $749K | Buy |
3,982
+2,943
| +283% | +$554K | ﹤0.01% | 901 |
|
|
2022
Q4 | $221K | Buy |
1,039
+172
| +20% | +$36.6K | ﹤0.01% | 1069 |
|
|
2022
Q3 | $136K | Buy |
867
+78
| +10% | +$12.2K | ﹤0.01% | 1120 |
|
|
2022
Q2 | $118K | Buy |
789
+17
| +2% | +$2.54K | ﹤0.01% | 1194 |
|
|
2022
Q1 | $126K | Buy |
772
+106
| +16% | +$17.3K | ﹤0.01% | 1195 |
|
|
2021
Q4 | $145K | Buy |
666
+58
| +10% | +$12.6K | ﹤0.01% | 1173 |
|
|
2021
Q3 | $115K | Buy |
608
+226
| +59% | +$42.7K | ﹤0.01% | 1126 |
|
|
2021
Q2 | $67K | Buy |
+382
| New | +$67K | ﹤0.01% | 1164 |
|